Results 191 to 200 of about 2,909 (219)
Current first‐line NUCs show comparable renal safety profiles in CHB patients with no or mild kidney dysfunction, with growing evidence that favours TAF. Future prospective studies are needed to validate these findings, and more research should focus on CHB patients with diabetes mellitus who are at risk of CKD.
Lung‐Yi Mak +2 more
wiley +1 more source
Effects of Inhibitors of the Activity of the Circulating Renin-Angiotensin System on the Growth and Proliferation of Endometrial Cancer Cells. [PDF]
Delforce SJ +6 more
europepmc +1 more source
Inactivation of CDK12 Enhances Mitochondrial Efficiency to Suppress DNA Damage
ABSTRACT Inactivation of cyclin‐dependent kinase 12 (CDK12) characterizes a subset of prostate cancers but it is not understood how cells adapt to declining activity of this major transcription elongation kinase. To probe this response, we developed a cell line resistant to an inhibitor targeting CDK12 and its paralog, CDK13.
Aishwarya Gondane +4 more
wiley +1 more source
ABSTRACT Aim This post‐marketing surveillance study determined the real‐world use and safety of ferric citrate hydrate (FC) in fetuses and pregnant women with iron deficiency anemia (IDA). Methods Pregnant women with IDA were registered centrally and followed prospectively from the first FC administration until the end of pregnancy or at treatment ...
Shinichiro Suzuki +9 more
wiley +1 more source
Wartime stress and relapse risk in people with multiple sclerosis: a prospective cohort study. [PDF]
Aloni R, Dror C, Barazani T, Kalron A.
europepmc +1 more source
ABSTRACT Since there are currently few antiviral drugs that can effectively reduce hepatitis B surface antigen levels, the recurrence rate remains high in patients with chronic hepatitis B (CHB) after discontinuing nucleoside analogues (NAs) treatment.
Dong‐Hui Wang +8 more
wiley +1 more source
Illusion of inactivity: Revisiting progressive multiple sclerosis treatment paradigms. [PDF]
Ganz T, Ben-Hur T.
europepmc +1 more source
Abstract figure legend 6‐Methylsulfinylhexyl isothiocyanate (6‐MSITC, hexaraphane), a wasabi sulfinyl compound, activates intracellular carbonic anhydrase (CA)‐mediated sequential HCO3−, Na+, H+ and Ca2+ transport through an activation axis involving HCO3−‐transporting solute carrier family 4 (SLC4As), the Na+–H+ exchanger (NHE), the Na+–Ca2+ exchanger
Yoshiaki Furusawa +9 more
wiley +1 more source
Biologics in Psoriasis; a Step towards Individualized Treatment [PDF]
Bezooijen, Sun-Jine
core +2 more sources

